84208-37-7

Basic information

• Product Name: 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetyl chloride hydrochloride
• Synonyms: 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetyl chloride hydrochloride
• CAS NO: 84208-37-7
• Molecular Weight: 539.781
• Mol File: 84208-37-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetyl chloride hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetyl chloride hydrochloride(84208-37-7)
• EPA Substance Registry System: 2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetyl chloride hydrochloride(84208-37-7)

Safety Data

• Hazardous Substances Data: 84208-37-7(Hazardous Substances Data)

Upstream product

• 84208-34-4 N-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxy>phthalimide 
• 84208-35-5 O-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethyl>hydroxylamine 
• 84208-33-3 p-nitrobenzyl 2-bromo-2-methylpropionate 
• 73181-65-4 ethyl (2-chloroacetamidothiazol-4-yl)glyoxylate 
• 73181-66-5 (2-chloroacetylamino-thiazol-4-yl)glyoxylic acid 
• 619-73-8 4-nitrobenzyl chloride 
• 19749-93-0 2-chloroacetamido-4-thiazolyl acetic acid ethyl ester 
• 84208-36-6 2-(2-chloroacetamido-4-thiazolyl)-(Z)-2-[1-methyl-1-(p-nitrobenzyloxycarbonyl)ethyloxyimino]acetic acid 

Downstream Products

• 78625-10-2 3-[2-(2-chloroacetamido-4-thiazolyl)-2-methoxyiminoacetamido]-2-oxoazetidine 
• 98376-58-0 (3S)-3-{2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-[1-methyl-1-(p-nitrobenzyloxycarbonyl)ethoxyimino]acetamido}-1-(p-nitrobenzyloxycarbonylmethoxy)-2-azetidinone 
• 98376-51-3 (3S,4S)-3-{2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-[1-methyl-1-(p-nitrobenzyloxycarbonyl)ethoxyimino]acetamido}-4-methyl-1-(p-nitrobenzyloxycarbonyl-methoxy)-2-azetidinone 
• 84164-44-3 sodium cis-3-<2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone-1-sulfonate 
• 84164-44-3 sodium trans-3-<2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone-1-sulfonate 
• 84164-45-4 sodium cis-3-<2-(2-aminothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone-1-sulfonate 
• 84164-45-4 sodium trans-3-<2-(2-aminothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone-1-sulfonate 
• 84208-38-8 trans-3-<2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone 
• 84164-50-1 Sodium; (2S,3S)-2-carbamoyl-3-{2-[2-(2-chloro-acetylamino)-thiazol-4-yl]-2-[(Z)-1-methyl-1-(4-nitro-benzyloxycarbonyl)-ethoxyimino]-acetylamino}-4-oxo-azetidine-1-sulfonate 
• 84208-38-8 cis-3-<2-(2-chloroacetamidothiazol-4-yl)-(Z)-2-<1-methyl-1-(4-nitrobenzyloxycarbonyl)ethoxyimino>acetamido>-4-methoxycarbonyl-2-azetidinone 

Relevant articles and documents

1-SULFO-2-OXOAZETIDINE DERIVATIVES AND THEIR PRODUCTION

Disclosed are compounds of the general formula: wherein R1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R is hydrogen, R or R4 where R is an organic residue attached to the azetidine ring through a carbon atom therein and R4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula wherein R5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof. The compounds have antimicrobial and/or beta-lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals

1-SULFO-2-OXOAZETIDINE DERIVATIVES AND THEIR PRODUCTION

Disclosed are compounds of the general formula: wherein R1 is amino, an acylated amino or a protected amino group, X is hydrogen or methoxy, and R" is hydrogen, R or R4 wherein R is an organic residue attached to the azetidine ring through a carbon atom therein and R4 is azido, a halogen, an amino group which may optionally be acylated or a group of the formula ?OR5, or ?S-S-R5 wherein R5 is an organic residue and n is 0, 1 or 2, and pharmaceutically acceptable salts and esters thereof. The compounds have antimicrobial and/or beta-lactamase-inhibitory activity and are of value as drugs for human beings and domesticated animals